Jeffreys Henry is one of the UK’s leading Auditors and Reporting Accountants to companies already listed, or considering listing, on the Aquis Stock Exchange (AQSE).

With a total of 31 UK listed clients,  and a further 25 listed on European markets, we are ranked 10th in the league table of Auditors by Total Stock Market Clients (as of November 2020).

WHAT IS THE AQUIS STOCK EXCHANGE?

An Aquis Stock Exchange (AQSE) quotation helps companies access new sources of capital to achieve their growth ambitions. Providing a clear, independent valuation and visible share price facilitates and encourages liquidity whilst our low free float requirement enables management to retain control.

Aquis Stock Exchange (AQSE) is a Recognised Investment Exchange under section 285 of the Financial Services and Markets Act 2000. AQSE must satisfy the requirements of the Financial Conduct Authority’s Recognition Requirements for Recognised Investment Exchanges and is responsible for maintaining neutral, well regulated and orderly markets.

AQSE Main Market

The AQSE Main Market is our market for larger companies with a track record of three years or more, as well as other issuers who are able to comply with the more demanding requirements of the UK Official List and associated UK Corporate Governance standards. Membership of this market gives companies access to the widest range of investors, both institutional and retail.

AQSE Growth Market

The AQSE Growth Market is our market for entrepreneurial companies seeking visibility and access to growth capital. Its regulatory framework is specifically designed to meet the needs of small and medium sized companies allowing management to concentrate on growing their business, whilst protecting investors.

Aquis Stock Exchange (AQSE)
Aquis Stock Exchange (AQSE)

FURTHER INFORMATION

NICK MICHAELS

Partner - Capital Markets


Throughout his career, Nick has extensively worked with public listed companies, including those listed on the LSE Standard List, AIM, Aquis (NEX) and CSE listed companies, during a time of accelerated growth, reverse takeovers and mergers and acquisitions.

SANJAY PARMAR

Partner - Capital Markets


Sanjay qualified as a Chartered Accountant in 1990. He is a corporate specialist with a client base in various sectors. Sanjay is the lead auditor on over 21 of our listed companies and has acted as the Reporting Accountant on a number of IPO’s and reverse transactions. He has extensive experience in the application of International Financial Reporting Standards (“IFRS”) and undertaking investigating accountant assignments on acquisitions.

JON ISAACS

Partner - Capital Markets


Since qualifying as a Chartered Accountant in 2000, Jon has been advising owner managed business in a number of sectors in respect of their financial and taxation affairs. Jon has also significant experience dealing with corporate finance work for a wide range of LSE, AIM and AQSE listed and unlisted companies and holds the ICAEW’s corporate finance qualification.

RELATED CAPITAL MARKETS NEWS

Our specialist teams offer expert insight into the issues that matter.

Jeffreys Henry Advise Aptamer Group plc on £80.7m AIM IPO

Jeffreys Henry, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has advised Aptamer Group Plc on its £80.7 million AIM IPO. On Admission, the market capitalisation of Aptamer Group was approximately £80.7 million. The Placing raised gross proceeds of £10.8 million and attracted strong support from high-quality institutional investors.

Jeffreys Henry advise Technology Minerals Plc on £27.3m LSE IPO

Jeffreys Henry, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Technology Minerals Plc on its £27.3 million IPO on the Standard Segment of LSE’s Main Market.

Jeffreys Henry advise Poolbeg Pharma Plc on £50m AIM IPO

Poolbeg Pharma, a spin out of Open Orphan, has successfully raised £25 million (before expenses) and lists with a market capitalisation of £50 million. Poolbeg Pharma is a clinical-stage infectious disease pharmaceutical company. Their novel capital light clinical model enables them to develop multiple products faster and more cost effectively than the traditional biotech model.

Jeffreys Henry Advise Vector Capital Plc on £16m AIM IPO

Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has advised Vector Capital Plc on its […]

Jeffreys Henry Advise Intuitive Investments Group on £7.85m AIM IPO

Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has advised Intuitive Investments Group on its […]

Jeffreys Henry Advise Anemoi International on LSE IPO

Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Anemoi International (“AMOI”) on its IPO on the Standard Segment of LSE’s main market.

Jeffreys Henry LLP advise Mode Global Holdings PLC on £40.3m LSE IPO

Jeffreys Henry LLP, the award-winning provider of audit, tax and advisory services to LSE, AIM and Aquis listed companies, has recently advised Mode Global Holdings Plc, a UK based founder led fintech group, on its £40.3 million IPO on the Standard Segment of LSE’s main market.

Shortlisted: Specialist Team of the Year 2020

We are delighted to announce that our specialist Capital Markets team have been shortlisted for one of the most hotly-contested trophies in the accountancy profession: Specialist Team of the Year 2020.

AIM listed Premier African Minerals appoints Jeffreys Henry LLP

We are pleased to announce that Jeffreys Henry LLP has replaced KPMG as auditor to AIM listed Premier African Minerals (AIM:PREM). Premier African Minerals Limited was […]

AIM listed Alien Metals appoints Jeffreys Henry LLP

We are pleased to announce that Jeffreys Henry LLP has replaced RSM as auditor to AIM listed Alien Metals (LSE: UFO). Alien Metals Ltd is a mining exploration and development company listed on AIM of the London Stock Exchange with a focus on precious and base metal commodities.